RESUMO
The Microgenics CEDIA DAU (EIA) and the Abbott AxSym system (FPIA) cannabinoids assays were evaluated for their combined effectiveness in the analysis of cannabinoids in whole blood. Blood samples were treated with acetone, evaporated, and reconstituted, and the supernatant was analyzed by the EIA cannabinoids assay. Blood samples determined positive by EIA were then treated with acetonitrile and sodium sulfate, and the resultant protein-free supernatant was analyzed using the FPIA cannabinoids assay. A total of 98 blood samples determined to be presumptively positive by both EIA and FPIA were further analyzed for the presence of 11-nor-carboxy-delta9-tetrahydrocannabinol-9-carboxylic acid (THCCOOH). All 98 blood samples could be confirmed for the presence of THCCOOH by gas chromatography-mass spectrometry (GC-MS) at concentrations greater than the 10 ng/mL cutoff. The GC-MS results were found to correlate significantly better with those of the FPIA cannabinoids assay (r = 0.75) than with EIA (r = 0.22). Procedures for the rapid analysis of whole blood for cannabinoids using CEDIA DAU reagents and the AxSym system are presented.
Assuntos
Canabinoides/sangue , Dronabinol/análogos & derivados , Imunoensaio de Fluorescência por Polarização , Técnicas Imunoenzimáticas , Acetona/química , Acetonitrilas/química , Dronabinol/sangue , Interações Medicamentosas , Cromatografia Gasosa-Espectrometria de Massas , Humanos , Padrões de Referência , Reprodutibilidade dos Testes , Solventes/química , Sulfatos/química , VolatilizaçãoRESUMO
The evaluation of new homogeneous enzyme immunoassay (EMIT) for benzodiazepines is described. The assay, although developed for direct analysis in serum, has been used to detect benzodiazepines in other body fluids and tissues; this is accomplished through two processes. The first consists of a previously reported technique of extraction and reconstitution of the original specimen. The second consists of dilution of the original specimen. The assay is compared to a gas chromatographic procedure.
Assuntos
Benzodiazepinas/análise , Benzodiazepinas/sangue , Benzodiazepinas/urina , Bile/análise , Cromatografia Gasosa , Humanos , Técnicas Imunoenzimáticas , Fígado/análise , Distribuição TecidualRESUMO
A procedure is presented for the concomitant identification and quantitation of certain commonly abused weak acid and natural drugs from whole blood. This procedure offers several advantages over other procedures in that: (A) a means of extraction of the drugs from blood using a very inexpensive source of diatomaceous earth (Celite 560) is presented, (B) the addition of three internal standards allows the quantitation of several drugs from blood with just one extraction of the blood sample, (C) the extracts are virtually free of any contaminants from biological sources or from biologically inert drug metabolites, and (D) the barbiturates and desmethyldiazepam are derivatized to enhance their limits of detection and reduce peak tailing frequently observed when using the nitrogen-phosphorous detector and gas chromatography (NPD/GC). Some 1000 positive driving-under-the-influence cases have been quantitated by this method.